These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6637187)

  • 1. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphology and pathogenesis of glomerular renal lesions in gold nephropathy].
    Waldmann G; Henzgen S
    Zentralbl Allg Pathol; 1983; 128(1-2):41-52. PubMed ID: 6415954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal biopsy appearances in rheumatoid disease.
    Sellars L; Siamopoulos K; Wilkinson R; Leohapand T; Morley AR
    Clin Nephrol; 1983 Sep; 20(3):114-20. PubMed ID: 6627762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
    Hall CL
    Adv Exp Med Biol; 1989; 252():247-56. PubMed ID: 2782197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological pictures of renal biopsy specimens in glomerulopathies related to rheumatoid arthritis (RA)].
    Danilewicz M; Wagrowska-Danilewicz M
    Przegl Lek; 1994; 51(1):5-8. PubMed ID: 8208996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study of membranous glomerulonephritis in patients with rheumatoid arthritis].
    Shimokama T; Baba N; Shouno Y; Watanabe T; Sakemi T; Harada A
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):301-7. PubMed ID: 1630032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature.
    Honkanen E; Törnroth T; Pettersson E; Skrifvars B
    Clin Nephrol; 1987 Feb; 27(2):87-93. PubMed ID: 3829481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 20. [The ultrastructural characteristics of minor glomerular abnormalities].
    Zou WZ
    Zhonghua Bing Li Xue Za Zhi; 1992 Oct; 21(5):266-8. PubMed ID: 1291147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.